BAK1 Gene

BAK1 Gene

Introduction

BAK1 (BCL2-Antagonist/Killer 1) is a pro-apoptotic member of the BCL2 family that functions as a mitochondrial outer membrane permeabilization (MOMP) effector. It promotes [apoptosis](/entities/apoptosis) by forming pores in the mitochondrial outer membrane, releasing cytochrome c and other pro-apoptotic factors into the cytosol. BAK1 plays a critical role in neuronal survival and its dysregulation contributes to neurodegenerative diseases. [@bak2003]

BAK1 Gene

Introduction

BAK1 (BCL2-Antagonist/Killer 1) is a pro-apoptotic member of the BCL2 family that functions as a mitochondrial outer membrane permeabilization (MOMP) effector. It promotes [apoptosis](/entities/apoptosis) by forming pores in the mitochondrial outer membrane, releasing cytochrome c and other pro-apoptotic factors into the cytosol. BAK1 plays a critical role in neuronal survival and its dysregulation contributes to neurodegenerative diseases. [@bak2003]

<div class="infobox infobox-gene"> [@bak2001]
<table> [@bak2009]
<tr><th colspan="2" class="infobox-header">BAK1 Gene</th></tr> [@bak2012]
<tr><td class="label">Gene Symbol</td><td>BAK1</td></tr> [@bak2015]
<tr><td class="label">Full Name</td><td>BCL2-Antagonist/Killer 1</td></tr> [@mitochondrial2014]
<tr><td class="label">Chromosomal Location</td><td>6p21.31</td></tr> [@bak2008]
<tr><td class="label">NCBI Gene ID</td><td>578</td></tr>
<tr><td class="label">UniProt ID</td><td>Q9YM15</td></tr>
<tr><td class="label">Ensembl ID</td><td>ENSG00000130165</td></tr>
<tr><td class="label">Protein Class</td><td>BCL2 family (pro-apoptotic)</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">77 edges</a></td>
</tr>
</table>
</div>

Overview

BAK1 is a 25 kDa protein localized primarily to the mitochondrial outer membrane. Unlike its close relative BAX, BAK1 is constitutively active and resides mainly on mitochondria. It is antagonized by anti-apoptotic BCL2 family members including BCL2, BCL-XL, and MCL1. Upon activation by BH3-only proteins (BIM, BID, PUMA), BAK1 oligomerizes to form large pores that permeabilize the mitochondrial outer membrane.

Protein Structure

BAK1 contains several functional domains:

• BH3 Domain (aa 73-87): Critical for activation by BH3-only proteins
• BH1 Domain (aa 125-145): Required for oligomerization and pore formation
• BH2 Domain (aa 155-175): Important for heterodimerization with anti-apoptotic proteins
• Transmembrane Anchor (aa 185-205): Mitochondrial outer membrane targeting

Normal Function

Mitochondrial Apoptosis Pathway

BAK1 is a key effector in the intrinsic (mitochondrial) apoptosis pathway:

Non-Apoptotic Functions

BAK1 also participates in:

• Mitochondrial Dynamics: Regulation of mitochondrial fission and fusion
• [Autophagy](/entities/autophagy): Selective mitophagy through interaction with autophagy receptors
• Cell Cycle Regulation: Checkpoint control in response to DNA damage

Role in Neurodegeneration

Alzheimer's Disease

BAK1-mediated neuronal apoptosis contributes to AD progression:

• Aβ-Induced Apoptosis: [Amyloid-beta](/proteins/amyloid-beta) oligomers increase BAK1 activation in [neurons](/entities/neurons)
• [Tau](/proteins/tau) Pathology: Hyperphosphorylated tau enhances BAK1-mediated cytochrome c release
• Synaptic Loss: BAK1 activation in synapses precedes overt neuronal death
• Therapeutic Target: BAK1 inhibitors may protect neurons from Aβ toxicity

Parkinson's Disease

• Mitochondrial Dysfunction: BAK1 activation is a downstream effect of mitochondrial complex I inhibition
• [α-Synuclein](/proteins/alpha-synuclein) Toxicity: BAK1 mediates dopaminergic neuron death induced by α-synuclein aggregates
• Leucine-Rich Repeat Kinase 2 (LRRK2): [LRRK2](/entities/lrrk2) G2019S mutations may sensitize neurons to BAK1-dependent apoptosis

Stroke and Ischemia

• Acute Neuronal Death: BAK1 is rapidly activated following cerebral ischemia
• Excitotoxicity: Glutamate-induced excitotoxicity activates BAK1-mediated apoptosis
• Therapeutic Window: BAK1 inhibition may provide neuroprotection if administered early

Amyotrophic Lateral Sclerosis (ALS)

• Motor Neuron Vulnerability: BAK1 activation contributes to sporadic and familial ALS
• SOD1 Mutations: Mutant SOD1 sensitizes motor neurons to BAK1-dependent apoptosis
• TARDBP (TDP-43): [TDP-43](/mechanisms/tdp-43-proteinopathy) pathology correlates with increased BAK1 activation

Traumatic Brain Injury (TBI)

• Secondary Injury: BAK1-mediated apoptosis contributes to progressive neuronal loss
• Axonal Degeneration: BAK1 activation in axons following trauma

Expression in the Brain

BAK1 is expressed throughout the central nervous system:

• Neurons: Moderate expression in cortical, hippocampal, and dopaminergic neurons
• [Astrocytes](/entities/astrocytes): Lower expression compared to neurons
• [Microglia](/cell-types/microglia-neuroinflammation): Constitutive expression; upregulated in neuroinflammation

Therapeutic Targeting

BAK1 Inhibitors

Several BAK1-selective inhibitors have been developed:

• BAK1 Inhibitor (BAK-IN-1): Selectively binds BAK1, prevents oligomerization
• ABT-737: Originally developed as BCL2/BCL-XL inhibitor, also has BAK1 activity at higher doses
• S63845: MCL1 inhibitor indirectly blocks BAK1 activation

Challenges

• Systemic Toxicity: BAK1 inhibition may impair immune cell function and tissue homeostasis
• [Blood-Brain Barrier](/entities/blood-brain-barrier): Drug delivery to CNS remains challenging
• Apoptotic vs. Non-Apoptotic Functions: Blocking all BAK1 functions may have unintended consequences

Combination Approaches

• With Anti-Amyloid Therapies: BAK1 inhibition may enhance neuronal survival during Aβ clearance
• With Neurotrophic Factors neuro: Combinedprotection strategies
• With Anti-inflammatory Agents: Addressing multiple death pathways

Interactions and Regulation

Pro-Apoptotic Partners

• BIM (BCL2L11)
• BID
• PUMA (BBC3)
• NOXA (PMAIP1)

Anti-Apoptotic Regulators

• BCL2
• BCL-XL (BCL2L1)
• MCL1
• BCL2A1

Signaling Pathways

• p53-mediated transcriptional activation of BAK1
• JNK/c-JUN pathway enhances BAK1 activation
• PI3K/AKT phosphorylates and inhibits BAK1

See Also

• [BCL2 Family](/proteins/bcl2-family)
• [Apoptosis Pathways](/mechanisms/apoptosis)
• [Mitochondrial Pores](/mechanisms/mitochondrial-apoptosis)
• [Cytochrome c](/proteins/cytochrome-c)
• [BAX Gene](/genes/bax)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)

Background

The study of Bak1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

References

Pathway Diagram

The following diagram shows the key molecular relationships involving BAK1 Gene discovered through SciDEX knowledge graph analysis: